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Background: Increasing numbers of systematic reviews evaluating the diagnostic test accuracy of technologies are
being published. Currently, review teams tend to apply conventional systematic review standards to identify
relevant studies for inclusion, for example sensitive searches of multiple bibliographic databases. There has been
little evaluation of the efficiency of searching only one or two such databases for this type of review. The aim of
this study was to assess the viability of an approach that restricted searches to MEDLINE, EMBASE and the reference
lists of included studies.
Methods: A convenience sample of nine Health Technology Assessment (HTA) systematic reviews of diagnostic
test accuracy, with 302 included citations, was analysed to determine the number and proportion of included
citations that were indexed in and retrieved from MEDLINE and EMBASE. An assessment was also made of the
number and proportion of citations not retrieved from these databases but that could have been identified from
the reference lists of included citations.
Results: 287/302 (95 %) of the included citations in the nine reviews were indexed across MEDLINE and EMBASE.
The reviews’ searches of MEDLINE and EMBASE accounted for 85 % of the included citations (256/302). Of the
forty-six (15 %) included citations not retrieved by the published searches, 24 (8 %) could be found in the reference
lists of included citations. Only 22/302 (7 %) of the included citations were not found by the proposed, more
efficient approach.
Conclusions: The proposed approach would have accounted for 280/302 (93 %) of included citations in this
sample of nine systematic reviews. This exploratory study suggests that there might be a case for restricting
searches for systematic reviews of diagnostic test accuracy studies to MEDLINE, EMBASE and the reference lists of
included citations. The conduct of such reviews might be rendered more efficient by using this approach.
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Increasing numbers of systematic reviews evaluating diag-
nostic technologies are being published in the field of
Health Technology Assessment (HTA). In response to the
needs of policy-makers in this field, in the last years, the
National Institute for Health and Care Excellence (NICE)
has established a Diagnostics Assessment Programme and
a Diagnostics Advisory Committee, having run a pilot pro-
ject to develop methods in this area [1, 2]. Systematic re-
views or individual studies of diagnostic test accuracy
usually compare an index test with the best available test
or current standard procedure for making a diagnosis.
The methodological challenges of undertaking systematic
reviews of diagnostic accuracy studies are well known and
have been extensively discussed in the academic literature
[3, 4]. Searching for and identifying evidence is one chal-
lenge when undertaking such a systematic review. Search
filters, including validated filters, are available from vari-
ous sources, but their use is now not recommended by
some organisations because the results from applying
these filters are variable [4, 5]. This is due in part to incon-
sistency in the reporting and indexing of papers. Conse-
quently, diagnostic study filters compare less favourably
with other search filters, e.g. for Randomised Controlled
Trials [4]. The Cochrane Collaboration Diagnostic Test
Accuracy Working Group is working on the publication
of diagnostic test accuracy systematic reviews within the
Cochrane Library and recognises the challenges of search-
ing for diagnostic studies. The Cochrane Handbook for
Systematic Reviews of Diagnostic Test Accuracy has a
chapter on searching for studies, which recommends that
“a range of databases be considered for searching”, includ-
ing MEDLINE, EMBASE and regional databases (to ac-
count for the differing disease prevalence within different
geographical regions) [6].
Within the information science community, there is
a growing interest in search efficiency, in particular
whether it is possible to identify the same sample of in-
cluded studies for a systematic review by searching fewer
databases than the traditionally large number deemed
necessary [7, 8]. This perhaps inevitable move has been
driven by several factors, including the improved index-
ing and searching capabilities of databases and the need
to produce high-quality reviews within time and re-
source constraints [9]. Consequently, it has been argued
that a well-structured search undertaken in only two or
three databases (supported by additional methods to
identify evidence, such as reference list checking, cit-
ation searching, contact with manufacturers and experts)
might identify evidence more efficiently than a similar
search undertaken in more databases [7].
Recent research evaluated whether searches for studies
of diagnostic test accuracy for systematic review and
meta-analysis could be limited to MEDLINE alone [10].Appraising 44 reviews of diagnostic test accuracy studies
containing 76 meta-analyses, the authors found that in
65 of the 76 meta-analyses (85.5 %), all of the studies
were identifiable in MEDLINE. Of the remaining 11
meta-analyses, 87.5–99 % of the studies were identifiable
in MEDLINE. Therefore, the authors suggest that exten-
sive searching in databases other than MEDLINE has
minimal effect on the identification of studies for inclu-
sion in diagnostic reviews. However, this conclusion as-
sumes that the actual searches undertaken in MEDLINE
for all 44 reviews would have had 100 % sensitivity: that
is, they would have retrieved all of the relevant studies
indexed in that database. In a separate study by the same
authors, statistical tests were also undertaken on a sub-
set of those meta-analyses for which not all included
studies were indexed in MEDLINE. This found that the
omission of any of the “missed” studies would not have
impacted on the basic findings of that sample, though
precision might be slightly affected [11].
An earlier study [12] sought to estimate the yield of
searches for studies of diagnostic test accuracy across
seven different databases by re-running the searches as
they were described for eight specific systematic reviews.
Taking the included studies from these reviews, the
authors created a gold standard set of included studies
(n = 522) and then categorised them as follows: 1) being
indexed in the databases and retrieved by the published
searches as they were described; 2) being indexed in the
databases but not retrieved by those searches; and 3)
not being indexed in any of the databases. The study
found that no search identified all of the included stud-
ies in the gold standard set for any one of the eight
reviews—even across all seven databases; that more than
20 % of the studies in any review were not identified by
the search of MEDLINE (EMBASE, Science Citation
Index and BIOSIS all contained studies that were not in
MEDLINE); that another 22/522 were not retrieved from
any of the seven databases using the reported searches,
and that 8/522 studies were not indexed in any of the
seven databases.
Given the different findings of these two studies
[10, 12] (i.e. the potential value of MEDLINE alone vs
the requirement to search multiple databases), there is a
strong case for further exploratory research in the area
of searching for diagnostic test accuracy studies for sys-
tematic reviews.
The aim of this study is therefore to examine whether
it would be worthwhile to limit searching for diagnostic
test accuracy studies to MEDLINE and EMBASE alone
(rather than searching a longer list of databases), along
with the standard systematic review supplementary tech-
nique of checking the references of included citations
and relevant reviews. This is the proposed strategy.
MEDLINE and EMBASE have been chosen as they are
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health sciences and have been found to be the most im-
portant sources of evidence in Health Technology As-
sessment [13]. They are routinely recommended as a
minimum for searches by bodies such as the Cochrane
Collaboration [6] and NICE [1], and they are the data-
bases with the majority of published search filters. The
addition of reference checking, as a supplementary
method, is also being assessed because it should be a
standard technique to identify literature in all systematic
reviews but its value as a search strategy has not yet
been evaluated by previous research into systematic re-
views of diagnostic test accuracy.
The specific objectives of this study therefore are to
analyse a convenience sample of systematic reviews of
diagnostic test accuracy studies in order to: 1) identify
which citations were indexed on MEDLINE or EMBASE;
2) to identify the number and proportion of citations
that were retrieved by the MEDLINE and EMBASE
search strategies reported for these reviews; 3) to identify
the number and proportion of studies that could have
been retrieved by the searches of MEDLINE and
EMBASE plus reference checking of studies identified as
relevant (any that could not be found by this proposed
strategy are referred to as “missing” citations); and, fi-
nally, 4) to detail the reported search strategies and con-
sider implications for literature searching for systematic
reviews of diagnostic test accuracy.
Methods
Identification of reviews and included citations indexed
on MEDLINE or EMBASE
We used a convenience sample test-set of nine Health
Technology Assessment systematic reviews of diagnostic
test accuracy undertaken at one centre: the School for
Health and Related Research (ScHARR) at the University
of Sheffield, UK. We selected these reviews because the
authors work at the same centre and were therefore able
to access full details of the searches. This represented all
of the diagnostic reviews undertaken for the National In-
stitute for Health Research (NIHR) HTA and NICE pro-
grammes by this centre. These reviews were published
between 2004 and 2014 and covered topics ranging from
neonatal screening to diagnostic tools for breast cancer,
heart and liver disease and stroke [5, 14–21]. For each sys-
tematic review, we identified the included citations and
searched for them to ascertain whether they were indexed
in MEDLINE and/or EMBASE regardless of whether they
had been retrieved by the reported searches.
Identification of included citations retrieved from
MEDLINE and EMBASE by the reported search strategies
For each systematic review, we also identified the ori-
ginal MEDLINE and EMBASE search strategies eitherfrom the reports or from the in-house project folders.
Where multiple search strategies were available, we
chose the search strategy for the systematic review of
diagnostic test accuracy (as opposed to modelling, preva-
lence etc.). We re-ran searches in June 2013 in MED-
LINE (Ovid platform) and EMBASE using the original
search strategies and date limits. The results were
imported into EndNote X1. This permitted an assess-
ment of the proportion of the citations in each review
that were identified by the published searches of MED-
LINE and EMBASE. The reports’ original Reference
Manager libraries were checked to identify the source of
any included studies that were not retrieved by these
searches of MEDLINE or EMBASE.
Identification of included citations not retrieved from
MEDLINE or EMBASE
The reference lists of included citations retrieved by the
searches reported for the respective reviews were also
checked by one author (CC) to determine the propor-
tion of non-retrieved citations that could still have been
identified using this standard, systematic review search-
ing method. Any citations that could not be found by
the proposed strategy of searching MEDLINE, EMBASE
and reference lists are listed as “missing studies”.
The search strategies
Finally, we detailed the basic elements of the search
strategies in terms of population and diagnostic test,
plus any limitations such as filters, language and date.
This enabled us to suggest reasons why included studies
might have been missed by the reported searches of
MEDLINE or EMBASE. Figure 1 describes the process.
Results
Characteristics of included reviews
We examined nine systematic reviews, published be-
tween 2004 and 2014. The total number of included ci-
tations was 302. The mean number of included studies
in these reviews was 34 (range 15–51). A total number
of 11 different databases were searched for evidence for
the reviews. In terms of the number of databases
searched per review, one review searched ten databases,
five reviews searched a total of nine databases, two re-
views searched eight databases and one review searched
seven databases. All reviews searched a minimum of the
following seven databases: MEDLINE, EMBASE, Central
Register of Controlled Trials (CENTRAL), Cochrane
Database of Systematic Reviews, NHS Database of Ab-
stracts of Reviews of Effects (DARE), Health Technology
Assessment (HTA) database and Web of Science (in-
cluding the Science Citation Index and Conference Pro-
ceedings Citation Index). Cumulative Index of Nursing
and Allied Health Literature was also searched for seven
Fig. 1 Summary of stages undertaken for each diagnostic review
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and Health Management Information Consortium for
one review each. See Table 1.
Number and proportion of included citations indexed on
MEDLINE or EMBASE
The nine reviews included 302 unique citations. Of
these, 275 (91 %) were indexed in MEDLINE and 277
(92 %) were indexed in EMBASE (see Table 2). In any
given review, the percentage of studies included in the
review that were indexed in MEDLINE ranged from 72
to 100 % and in EMBASE ranged from 66 to 100 %.
Across both databases, it ranged from 85 to 100 %.
Across the 302 citations, 287 (95 %) were indexed in ei-
ther MEDLINE or EMBASE or both. Of the 287 indexed
studies, 265 (88 %) studies were indexed in both data-
bases and so could have been found by searching just
one of them: ten studies were unique to MEDLINE and
12 were unique to EMBASE. In five of the nine reviews,
all of the included citations were indexed in either MED-
LINE or EMBASE; in one review, only two citations
were not indexed in either database; in two reviews, only
four were not indexed; and in a single review, five were
not indexed.Number and proportion of included citations retrieved by
the reported MEDLINE and EMBASE search strategies
The number of citations identified in MEDLINE or
EMBASE using the reported search strategies for each
review was lower than the number of indexed citations
that could have been potentially identified (i.e. those
indexed in MEDLINE or EMBASE but not retrieved by
the reported searches). Across all reviews, the percent-
age of included citations retrieved by the published
search strategies ranged from 60 to 100 % in MEDLINE
and from 18 to 87 % in EMBASE. The proportion of ci-
tations found by the searches across both MEDLINE
and EMBASE in the reviews ranged from 60 to 100 %.
In total, the searches of MEDLINE and EMBASE identi-
fied 256/302 (85 %) of the included citations in these
nine systematic reviews (see Table 3). The searches
undertaken in MEDLINE and EMBASE found 100 % of
the included citations in one review (Kaltenthaler [21])
and only missed a single citation in two reviews (Simp-
son [15], Sutcliffe [19]); in five reviews, between five and
seven citations were not found by the searches. Only the
MEDLINE or EMBASE searches undertaken for one
review, Holmes [5], missed a sizeable number (14/51 =
27 %) of its included citations (even though all 14
Table 1 Included reviews
Review Topic Number of
included studies
Number and names of databases searched
Holmes (2014) Routine echocardiography in the management
of stroke and transient ischemic attack (TIA)
51 (n = 9) MEDLINEa, EMBASE, CENTRAL, CDSR, NHS
DARE, HTA, CINAHL, Web of Science, PsycINFO
Ward (2013) Gene expression profiling and expanded
immunohistochemistry tests to guide the use
of adjuvant chemotherapy in breast cancer
32 (n = 8) MEDLINEa, EMBASE, CENTRAL, CDSR, NHS
DARE, HTA, BIOSIS, Web of Science
Simpson (2013) Echocardiography in newly diagnosed atrial
fibrillation patients
44 (n = 7) MEDLINEa, EMBASE, CENTRAL, CDSR, NHS
DARE, HTA, Web of Science
Goodacre (2013) Diagnostic strategies for suspected acute
coronary syndrome
40 (n = 8) MEDLINEa, EMBASE, CENTRAL, CDSR, NHS
DARE, HTA, CINAHL, Web of Science
Stevenson (2012) Non-invasive diagnostic assessment tools for
the detection of liver fibrosis in patients with
suspected alcohol-related liver disease
17 (n = 9) MEDLINEa, EMBASE, CENTRAL, CDSR, NHS
DARE, HTA, CINAHL, Web of Science, BIOSIS
Cooper (2011) Imaging for the assessment of axillary lymph
node metastases in early breast cancer
45 (n = 9) MEDLINEa, EMBASE, CENTRAL, CDSR, NHS
DARE, HTA, CINAHL, Web of Science, BIOSIS
Sutcliffe (2009) Classical and novel biomarkers as prognostic
risk factors for localised prostate cancer
30 (n = 9) MEDLINEa, EMBASE, CENTRAL, CDSR, NHS
DARE, HTA, CINAHL, Web of Science, BIOSIS
Pandor (2004) Neonatal screening for inborn errors of
metabolism using tandem mass spectrometry
15 (n = 10) MEDLINEa, EMBASE, CENTRAL, CDSR, NHS
DARE, HTA, CINAHL, Web of Science, BIOSIS, HMIC
Kaltenthaler (2004) magnetic resonance cholangiopancreatography
compared with diagnostic endoscopic retrograde
cholangiopancreatography
28 (n = 9) MEDLINEa, EMBASE, CENTRAL, CDSR, NHS
DARE, HTA, CINAHL, Web of Science, BIOSIS
Total 302
aIncluding MEDLINE in-process and other non-indexed citations
CENTRAL Cochrane Central Database of Controlled Trials, CDSR Cochrane Database of Systematic Reviews, DARE NHS Database of Abstracts of Reviews of Effects,
HTA Health Technology Assessment database, CINAHL Cumulative Index of Nursing and Allied Health Literature, various databases Web of Science, BIOSIS
previews/biological abstracts, HMIC Health Management Information Consortium
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Table 2).
Sources of citations not retrieved from MEDLINE and
EMBASE using the reported searches
The reported searches of MEDLINE and EMBASE
therefore failed to identify 46 out of the 302 total in-
cluded citations (15 %) (see Table 3). Thirty-one of theseTable 2 Included citations indexed in MEDLINE and EMBASE (n/%)
Project Included
studies (n = )
Included studies
indexed in MEDLINE
Included studies
indexed in EMBASE
Holmes (2014) 51 48 (94 %) 51 (100 %)
Ward (2013) 32 23 (72 %) 27 (84 %)
Simpson (2013) 44 44 (100 %) 44 (100 %)
Goodacre (2013) 40 38a (95 %) 40 (100 %)
Stevenson (2012) 17 12 (80 %) 13 (87 %)
Cooper (2011) 45 40 (89 %) 39 (87 %)
Sutcliffe (2009) 30 29 (97 %) 30 (100 %)
Pandor (2004) 15 13 (87 %) 10 (66 %)
Kaltenthaler
(2004)
28 28 (100 %) 23 (82 %)
Total 302 275 (91 %) 277 (92 %)
aOne had not been fully published at the time of the report but existed as an “epucitations (11 %) were indexed in either MEDLINE or
EMBASE but were not retrieved by these searches. The
number of citations not retrieved by the MEDLINE or
EMBASE searches varied by review from 0 to 14. For all
but one of the reviews, additional sources were used to
locate the included citations in each review (Table 4).
The most common reported sources of citations not
identified via MEDLINE or EMBASE was searching ofIncluded studies
indexed in both
MEDLINE and EMBASE
Included studies indexed in
one database but not the
other: MEDLINE/EMBASE
Included studies not
indexed in either
MEDLINE or EMBASE
48/51 (94 %) 0/3 0
22/32 (69 %) 1/5 4
44/44 (100 %) 0/0 0
38/40 (95 %) 0/2 0
12/17 (80 %) 0/1 4
39/45 (87 %) 1/0 5
29/30 (97 %) 0/1 0
10/15 (66 %) 3/0 2
23/28 (82 %) 5/0 0
265 (88 %) 10/12 15 (5 %)
b”, but it would have been retrieved by the strategy
Table 3 Included studies found by reported searches of MEDLINE and EMBASE (n/%)
Project Included studies Included studies
identified in MEDLINE
via search
Included studies
identified in EMBASE
via search
Total included studies
retrieved by search across
both MEDLINE and EMBASE
Total included studies indexed
in MEDLINE and EMBASE but
missed by the reported searches
Holmes (2014) 51 31 (61 %) 25 (49 %) 37/51 (73 %) 14/51
Ward (2013) 32 20 (63 %) 25 (78 %) 26/32 (81 %) 2/32
Simpson (2013) 44 43 (98 %) 24 (55 %) 43/44 (98 %) 1/44
Goodacre (2013) 40 27 (68 %) 27 (68 %) 34/40 (85 %) 6/40
Stevenson (2012) 17 11 (65 %) 11 (65 %) 12/17 (71 %) 1/17
Cooper (2011) 45 38 (84 %) 34 (76 %) 38/45 (84 %) 2/45
Sutcliffe (2009) 30 27 (90 %) 26 (87 %) 29/30 (97 %) 1/30
Pandor (2004) 15 9 (60 %) 4 (27 %) 9/15 (60 %) 4/15
Kaltenthaler (2004) 28 28 (100 %) 5 (18 %) 28/28 (100 %) 0/28
Total 302 234 (77 %) 181 (60 %) 256 (85 %) 31 (11 %)
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base (Science Citation Index) (14 papers). Other data-
bases that were a source of included papers were BIOSIS
(3 papers), PubMed (1 paper) and CINAHL (1 paper).
The four databases available via the Cochrane Library
(CENTRAL, CDSR, DARE and HTA), plus PsycINFO
and Health Management Information Consortium did
not identify any unique citations for these nine system-
atic reviews of diagnostic test accuracy studies.Table 4 Reported and potential sources of citations not retrieved fr
Project Included studies
not retrieved by
search of both
MEDLINE/EMBASE
Sources of non-retrieved
citations as reported
in the reviews
Non-retrie
identifiabl
reference
retrieved
and review
Holmes (2014) 14/51 Reference lists (11),
WoS (2), Google (1)
13
Ward (2013) 6/32 Manufacturer (1),
NR (5)
2
Simpson (2013) 1/44 NR (1) 0
Goodacre (2013) 6/40 WoS (4), CINAHL (1),
personal contact (1)
5
Stevenson (2012) 5/17 WoS (3), Manufacturer
(1), BIOSIS previews (1)
1
Cooper (2011) 7/45 WoS (3), BIOSIS previews
(2), reference lists (1),
PubMed (1)
0
Sutcliffe (2009) 1/30 WoS (1) 0
Pandor (2004) 6/15 Reference lists (4), WoS
(1), NR (1)
3
Kaltenthaler (2004) 0/28 None 0
Total 46/302 (15 %) Reference lists (16),
WoS (14), NR (7),
BIOSIS (3), others (6)
24/46 (52
WoS Web of Science, NR not reported
aCitations not retrieved by the reported searches of MEDLINE or EMBASE or include
relevant reviews“Missing” citations
For the purposes of this study, an assessment was also
made to determine the proportion of non-retrieved cita-
tions that could have been identified from the references
of retrieved citations: an approach which should be part
of any systematic review search strategy (Table 4). This
assessment found that 24/46 (52 %) of these citations
were in the reference lists of other included citations in
their respective reviews and so should or could haveom MEDLINE and EMBASE (n/%)
ved citations
e from
lists of
studies
s
Total identifiable from
reported searches of
MEDLINE, EMBASE,
plus reference checking
of included studies
and reviews
Remaining citations
published as
abstracts only
“Missing”
citationsa
50/51 (98 %) 0 1
28/32 (88 %) 2 2
43/44 (98 %) 0 1
39/40 (98 %) 0 1
13/17 (76 %) 3 1
38/45 (84 %) 5 2
29/30 (97 %) 0 1
12/15 (80 %) 2 1
28/28 (100 %) 0 0
%) 280/302 (93 %) 12/46 (26 %) 10/46 (22 %)
d after reference checking of any of these retrieved citations or
Table 5 Basic details of MEDLINE search strategies
Report Population Test Filter Other, e.g. date Totals retrieved (n =MEDLINE
and EMBASEa/all databasesb)
MesH Free-text MeSH Free-text
Holmes (2014) Yes Yes Yes Yes Yes No 12,006/13,075 (92 %)
Ward (2013) Yes Yes Yes Yes No 2009 onwards 2415a/5990 (40 %)
Simpson (2013) Yes Yes Yes Yes Yes Human only 12,816/15,824 (81 %)
Goodacre (2013) Yes Yes Yes Yes Yes Human only, 1995 onwards 1607/2865 (56 %)
Stevenson (2012) No Yes Yes Yes Yes No 2265a/4039 (56 %)
Cooper (2011) Yes Yes Yes Yes Yes No 377/646 (58 %)
Sutcliffe (2009) Yes Yes No No Yes No 10,070a/12,963 (78 %)
Pandor (2004) Yes Yes Yes Yes No No 108a/145 (74 %)
Kaltenthaler (2004) No No Yes Yes No No 1437a/1437 (100 %)
43,101/56,984 (76 %)
aEither from the re-run of searches in June 2013 or the project reference management databases, both with duplicates removed
bThis number is taken from the final review’s PRISMA flow diagram and is usually with duplicates removed
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MEDLINE, EMBASE and reference checking therefore
could have identified 280 (93 %) of the 302 citations in-
cluded in the review sample. Consequently, there were
22/302 (7 %) “missing citations”. Of these, 12/46 (26 %)
were abstracts not indexed in MEDLINE or EMBASE so
could not be retrieved by searches of these databases.
The other ten citations (3 % of the total citations across
all reviews) were eight standard journal articles, a book
chapter and an unpublished study submitted by the
manufacturer [14].
Details of the reported MEDLINE and EMBASE search
strategies
The MEDLINE and EMBASE search strategies were re-
corded in the reports. The strategies were all con-
structed following standard techniques, breaking-down
the search into its constituent parts and combining them
in an appropriate manner: population; diagnostic test
(index test); and, in some of these cases, a published fil-
ter for diagnostic studies or other restrictions [6]. In
every review, for each part of the strategy, both free-text
and, where appropriate, MeSH terms were used. See
Table 5. None of the searches included terms for com-
parator tests (best available or current standard proced-
ure) or outcomes. As a result, they were all arguably
relatively sensitive searches. Some reviews applied few
restrictions (and therefore achieved greater potential
sensitivity) if the numbers retrieved were relatively small
(e.g. [17, 20, 21]). The final column of Table 5 also dem-
onstrates that MEDLINE and EMBASE could be respon-
sible for as little 40 % [14] or as much as 100 % [21] of
the total retrieved citations that needed screening. These
databases accounted for 76 % of the citations screened
across the nine reviews. A sizeable number of citations(24 %) might therefore have been removed from the study
screening process by reducing the number of databases:
across the nine reviews, after de-duplication of records in
the reference management databases, 13,883 citations
were screened that were not retrieved from either MED-
LINE or EMBASE and could only have generated, as a
maximum, 18 out of the 22 “missing” citations (two were
provided by a manufacturer, one was identifiable by per-
sonal communication only and one from Google).
Discussion
The sample of systematic reviews covered here searched
between seven and nine databases although some of
these databases are principally or exclusively index sys-
tematic reviews (CDSR, DARE and HTA) and so were
unlikely to produce many individual diagnostic test ac-
curacy studies. However, the reported searches of MED-
LINE and EMBASE alone, plus the checking of the
reference lists of relevant papers, would have accounted
for 280 (93 %) of the total included citations across all
nine reports and 100 % of the included citations in four
of the nine reports ([15, 16, 19, 21]).
In terms of indexed citations, the findings for MED-
LINE (91 %) are similar to those reported by Van Enst
and colleagues [10]. However, this percentage does not
indicate what was identified by the searches that were
developed and run for these particular reviews but only
what could potentially have been identified based on the
proportion of indexed citations. In the present study, the
proportion of citations found by the actual searches
across both MEDLINE and EMBASE in the reviews
ranged from 60 to 100 %. Consequently, the evidence of
this sample suggests that, on the whole, MEDLINE alone
cannot be relied on to act as a single source database for
systematic reviews of studies of diagnostic test accuracy.
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standard principles, but more sensitive searches might
have had the potential to identify all of the indexed and
included citations in each of these four reviews and to
miss only the 15 non-indexed citations across the other
five reviews. Searches could have been made more sensi-
tive by the addition of further keywords or free-text
terms or the removal of certain terms or sets of terms:
for example, the reports by Kaltenthaler [21] and
Sutcliffe [19] did not use filters, and the former did not
use terms for the population and the latter did not use
terms for the index test (Table 5). However, a more
sensitive search would have also increased the number
of hits and the size of the task involved in screening cita-
tions for inclusion, which can create practical problems
for Health Technology Assessments which are required
to produce reports within time constraints [9, 22]. For
example, the searches conducted in MEDLINE and
EMBASE for the review by Holmes et al. [5] only
retrieved 37 of a possible 51 of the included citations
(73 %) that were indexed in these databases. This repre-
sents a relatively low retrieval rate. The search strategy
does appear to have been less sensitive than most other
reviews with the exception of those by Simpson [15] and
Goodacre [16], which applied the same or more limita-
tions in terms of including all possible elements of a
search (see Table 5). However, the searches from this re-
view also generated the second largest number of cita-
tions for screening (13,075); the largest was one of the
reviews with the least sensitive searches: Simpson [15]
with 15,824 citations. The need to maintain manageable
numbers for study selection screening would explain the
development of these less sensitive searches.
Although the use of filters is not recommended for re-
views of diagnostic test accuracy studies, some of the
reviews in this sample pre-date this guidance from
Cochrane and NICE. More importantly, it should be
noted that the aims of Health Technology Assessments
differ from Cochrane reviews: HTA reports address
questions that are more complex than just a question of
diagnostic accuracy, for example, the opportunity costs
of implementing diagnostic strategies vs going straight
to treatment. It is often strategies that are being com-
pared, not just tests. So, in many of these reports, there
are a number of other questions also being addressed and
searched for, including adverse events, quality of life and
cost-effectiveness. Working within time and resource con-
straints to produce such reports might require a more
pragmatic approach to searching, such as the application
of filters, when otherwise sensitive searches produce un-
manageable numbers of citations [8, 22].
Twenty-two citations (7 %) could not be identified
by the proposed method of searching just MEDLINE,
EMBASE and the references of retrieved citations. Twelveof these citations were abstracts. Published abstracts
should not be ignored, especially because studies included
in systematic reviews of diagnostic test accuracy can take
the form of ad hoc analyses rather than registered trials.
They might offer key data for assessing and managing
publication bias [23] and, for some topics, these data
might be vital for a review’s findings, especially for tests
about which little has been published, for instance if the
technique is novel [24, 25].
It is true that the usefulness of abstracts might be lim-
ited by their lack of detail, which can prevent a meaning-
ful assessment of risk of bias and can render data more
uncertain. However, in this case study, all of the ab-
stracts missed by the searches of MEDLINE, EMBASE
and the reference lists did satisfy the reviews’ inclusion
criteria and were used in their analyses. It should be
mentioned also that the majority of the reviews performed
narrative synthesis rather than meta-analysis, so the im-
pact of their possible omission is difficult to quantify.
However, given the very small proportion of “missing”
studies, their impact on the findings on the respective re-
views is likely to have been minimal.
The diagnostic topics covered by the nine systematic
reviews were diverse and were undertaken over an ex-
tended period (2004–2014), so, other than their conduct
by a single centre, this does not represent a particularly
restricted sample. This evidence indicates that an ap-
proach that involves searching MEDLINE and EMBASE
using strategies constructed by applying standard sys-
tematic review techniques, then carefully checking the
references of included papers, is likely to be more than
sufficient for a systematic review of diagnostic studies.
In this way, only 22/302 (7 %) of citations would have
been missed across nine reviews and, in four reviews, no
citations would be missed at all. Such a level of omission
is unlikely to adversely affect the findings of systematic
reviews of diagnostic test accuracy: it has been demon-
strated that a larger percentage of missed studies had lit-
tle effect on meta-analyses of a sample of diagnostic test
accuracy reviews [11]. This approach would also save a
great deal of time and effort and, given the smaller num-
bers of citations needing screening, would possibly also
reduce the risk of reviewer error in selecting citations
for potential inclusion. This would permit a more rapid
evidence synthesis, whilst not compromising systematic
review principles or increasing the risk of bias [22].
Limitations
This study used a small, non-random sample of diagnos-
tic test accuracy systematic reviews. This was done for
reasons of pragmatism: first, because the authors had
full access to the search strategies and reference data-
bases of these reviews and, second, because of the ex-
ploratory nature of this project. We also assumed that
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were located through screening of titles, abstracts and
full papers. We have also assumed, because the number
of studies missed by operating the proposed MEDLINE,
EMBASE and reference tracking strategy is so small that
the findings of the systematic reviews would not have
been greatly affected by their omission. However, this is
uncertain and can only be assessed statistically by ex-
cluding those particular studies from the many analyses
reported in the reviews, although, as noted above, most
of these reviews conducted narrative synthesis. Such an
analysis is a major task to undertake retrospectively and
has therefore not been completed in this exploratory
study. Future work should test the findings of this small
study in a larger, preferably prospective sample of sys-
tematic reviews from multiple institutions. If possible,
statistical analysis should also be undertaken to quantify
fully the impact of omitting any data from studies that
might otherwise be missed [11].
Conclusions
This small study seeks to add to the otherwise limited
amount of research in this field. It differs from Van Enst
and colleagues [10] by indicating that systematic reviews
of diagnostic test accuracy studies do require searching
of both MEDLINE and EMBASE, rather than MEDLINE
alone, if they are to successfully identify all or almost all
relevant citations. It also differs from Whiting and col-
leagues [12] by indicating that a search conducted using
MEDLINE and EMBASE alone, supplemented by stand-
ard reference checking, was able to successfully identify
all or almost all relevant citations: The searching of mul-
tiple databases is therefore not required. Depending on
the topic, the search of a database of conference pro-
ceedings might also be required. The process therefore
becomes more simple, contained and arguably more effi-
cient, whilst not increasing the risk of bias or comprom-
ising the key principles of systematic review.
Abbreviations
CDSR: Cochrane Database of Systematic Reviews; CENTRAL: Central Register
of Controlled Clinical Trials; DARE: Database of Abstracts of Reviews of
Effects; HTA: Health Technology Assessment; NICE: National Institute for
Health and Care Excellence; NIHR: National Institute for Health Research;
RCT: Randomised Controlled Trial.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
CC conceived of the study, participated in its design, coordination and
conduct and drafted the manuscript. LB coordinated the project and helped
to draft the manuscript. SP and EK helped to coordinate the project and to
draft the manuscript. PG carried out the majority of the database searching.
All authors read and approved the final manuscript.
Acknowledgements
This work received no funding.Author details
1School of Health and Related Research (ScHARR), University of Sheffield,
Sheffield S1 4DA, England. 2Department of Public Health and Pediatrics,
University of Turin, Piazza Polonia, 94, 10125 Turin, Italy.
Received: 10 March 2015 Accepted: 3 June 2015
References
1. National Institute for Health and Clinical Excellence Centre for Health
Technology Evaluation Diagnostics Assessment Programme. Report on pilot
project on the assessment of non-invasive diagnostic assessment tools for
the detection of liver fibrosis in patients with suspected alcohol related liver
disease. London: NICE; 2011.
2. National Institute for Health and Clinical Excellence. Diagnostics Assessment
Programme manual. Manchester: NICE; 2011.
3. Whiting P, Rutjes AW, Westwood M, Mallett S, Deeks JJ, Reitsma JB, et al.
QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy
studies. Ann Intern Med. 2011;155:529–36.
4. Leeflang M, Deeks JJ, Gatsonis C, Bossuyt P. Cochrane Diagnostic Test
Accuracy Working Group. Systematic reviews of diagnostic test accuracy.
Ann Intern Med. 2008;149:889–97.
5. Holmes M, Rathbone J, Littlewood C, Rawdin A, Stevenson M, Stevens JW,
et al. Routine echocardiography in the management of stroke and transient
ischemic attack (TIA): a systematic review and an economic evaluation.
Health Technol Assess. 2014;18(16):1–176.
6. de Vet HCW, Eisinga A, Riphagen II, Aertgeerts B, Pewsner D. Chapter 7:
Searching for Studies. In: Cochrane Handbook for Systematic Reviews of
Diagnostic Test Accuracy Version 0.4 [updated September 2008]. The
Cochrane Collaboration. 2008.
7. Beyer F, Wright K. Can we prioritise which databases to search? A case
study using a systematic review of frozen shoulder management. Health
Info Lib J. 2012;30:49–58.
8. Booth A. How much searching is enough? Comprehensive versus optimal
retrieval for technology assessments. Int J Technol Assess Health Care.
2010;26:431–5.
9. Egger M, Juni P, Bartlett C, Holenstein F, Sterne J. How important are
comprehensive literature searches and the assessment of trial quality in
systematic reviews? Empirical study. Health Technol Assess. 2003;7(1):1–76.
10. Van Enst WA, Scholten RJPM, Hooft L. Could a search for a diagnostic test
accuracy review be restricted to MEDLINE? Madrid: Cochrane Colloquium; 2011.
11. Van Enst WA, Scholten RJPM, Whiting P, Zwinderman A, Hooft L. Meta-
epidemiologic analysis indicates that MEDLINE searches are sufficient for
diagnostic test accuracy systematic reviews. J Clin Epidem. 2014;67:1192–9.
12. Whiting P, Westwood M, Burke M, Sterne J, Glanville J. Systematic reviews of
test accuracy should search a range of databases to identify primary studies.
J Clin Epidem. 2008;61:357. e.1-357.e.10.
13. Royle P, Waugh N. Literature searching for clinical and cost-effectiveness
studies used in health technology assessment reports carried out for the
National Institute for Clinical Excellence appraisal system. Health Technol
Assess. 2003;7(34):iii, ix–x, 1–51.
14. Ward SE, Scope A, Rafia R, Pandor A, Harnan S, Evans P. Gene expression
profiling and expanded immunohistochemistry tests to guide the use of
adjuvant chemotherapy in breast cancer management: a systematic review
and cost-effectiveness analyses. Health Technol Assess. 2013;17(44):1–302.
15. Simpson E, Stevenson M, Scope A, Poku E, Minton J, Evans P.
Echocardiography in newly diagnosed atrial fibrillation patients: a systematic
review and economic evaluation. Health Technol Assess. 2013;17(36):1–263.
16. Goodacre S, Thokala P, Carroll C, Stevens JW, Leaviss J, Al Khalaf M et al.
Systematic review, meta-analysis and economic modelling of diagnostic
strategies for suspected acute coronary syndrome. Health Technol Assess.
2013; 17. doi: 10.3310/hta17010
17. Stevenson M, Lloyd-Jones M, Morgan M, Wong R. Non-invasive diagnostic
assessment tools for the detection of liver fibrosis in patients with sus-
pected alcohol-related liver disease: a systematic review and economic
evaluation. Health Technol Assess. 2012;16(4):1–174.
18. Cooper KL, Meng Y, Harnan S, Ward SE, Fitzgerald P, Papaioannou D et al.
Positron emission tomography (PET) and magnetic resonance imaging
(MRI) for the assessment of axillary lymph node metastases in early breast
cancer: systematic review and economic evaluation. Health Technol Assess.
2011;15. doi: 10.3310/hta15040
Preston et al. Systematic Reviews  (2015) 4:82 Page 10 of 1019. Sutcliffe P, Hummel S, Simpson E , Young T, Rees A, Wilkinson A et al. Use
of classical and novel biomarkers as prognostic risk factors for localised
prostate cancer: a systematic review. Health Technol Assess. 2009;13.
doi: 10.3310/hta13050
20. Pandor A, Eastham J, Beverley C, Chilcott J, Paisley S. Clinical effectiveness
and cost-effectiveness of neonatal screening for inborn errors of
metabolism using tandem mass spectrometry: a systematic review. Health
Technol Assess. 2004;8(12):iii. 1-121.
21. Kaltenthaler E, Bravo Vergel Y, Chilcott J, Thomas S, Blakeborough T, Walters
SJ, et al. A systematic review and economic evaluation of magnetic
resonance cholangiopancreatography compared with diagnostic
endoscopic retrograde cholangiopancreatography. Health Technol Assess.
2004;8(10):iii. 1-89.
22. Schünemann HJ, Moja L. Reviews: Rapid! Rapid! Rapid! …and systematic.
Syst Reviews. 2015;4(1):4.
23. Leeflang M, Deeks JJ, Takwoingi Y, Macaskill P. Cochrane diagnostic test
accuracy reviews. Syst Reviews. 2013;2:82.
24. Song F, Khan KS, Dinnes J, Sutton AJ. Asymmetric funnel plots and
publication bias in meta-analyses of diagnostic accuracy. Int J Epidem.
2002;31:88–95.
25. Scherer R, Dickersin K, Langenberg P. Full publication of results initially
presented in abstracts: a meta-analysis. JAMA. 1994;272:158–62.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
